Do you offer durvalumab to patients with stage IIIB NSCLC after chemoradiation if they are also on long term dialysis for ESRD?

Antibodies are generally not dialyzable with conventional methods. Given the cancer diagnosis, these patients are not candidates for transplant in the short term. With a prognosis of advanced stage NSCLC worse than the prognosis arising from ESRD already on long-term dialysis, I will offer the optio...